Pharmacokinetics and tolerability of three ordopidine dose levels in volunteers
Phase of Trial: Phase I
Latest Information Update: 26 Jun 2008
At a glance
- Drugs Ordopidine (Primary)
- Indications Bipolar disorders; Parkinson's disease
- Focus Pharmacokinetics
- Sponsors NeuroSearch
- 26 Jun 2008 Status changed from in progress to completed, according to a NeuroSearch media release (9090561).
- 10 Nov 2006 The expected completion date for this trial is now 30 Jun 2007.
- 10 Nov 2006 New trial record.